🔎 Trials Near Me

ホーム › 腎臓がん（腎細胞がん） › ミシガン州

ミシガン州における腎臓がん（腎細胞がん）の臨床試験

ミシガン州内の拠点で、腎臓がん（腎細胞がん）に関する29件の研究が参加者を募集しています。

ミシガン州内の都市

公式研究テキスト（英語）

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Detroit
  • Research Site, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Grand Rapids Site, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07300241

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • South Texas Accelerated Research Therapeutics (START), Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • 他68件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #65, Detroit
  • Exelixis Clinical Site #13, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health Medical Center - Brighton, Brighton
  • 他32件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  • Local Institution - 0176, Big Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07293351

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

  • Henry Ford Health, Detroit
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/18更新 · NCT07828704

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • 他12件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • University of Michigan, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Cancer & Hematology Centers of Western Michigan, Grand Rapids
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • Bronson Battle Creek, Battle Creek
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
  • 他17件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07115043

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

  • University of Michigan, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06966024

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06866262

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Henry Ford Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • Henry Ford Health, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT03972657

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
  • 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/11更新 · NCT07383441

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

  • Henry Ford Health System, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/08更新 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

  • University of Michigan, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/20更新 · NCT06053658

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  • Start Midwest Cancer Research, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/28更新 · NCT06413680

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Henry Ford Cancer Institute, Detroit
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/17更新 · NCT05856981

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

  • University of Michigan Hospitals, Ann Arbor
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/23更新 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • University of Michigan - Brighton Center for Specialty Care, Brighton
  • 他15件
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/09更新 · NCT04510597

A Beta-only IL-2 ImmunoTherapY Study

  • Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692

A Study of IBI363 in Subjects with Advanced Solid Malignancies

  • Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
  • Michigan Hematology & Oncology Consultants - MedOnc Troy, Troy
被験者募集中第2相
18歳以上 · 全性別 · 2024/12/19更新 · NCT06281678

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。